Long-term effects of combined immunosuppressive treatment on myasthenic crisis

European Journal of Neurology

Volumn 16, Issue 7, 2009, Pages 796-800

  Rozsa C ^b   Mikor, A ^a   Kasa, K ^b   Illes, Z ^a   Komoly, S ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Jahn Ferenc Del Pesti korhaz Budapest   (Hungary)

Author keywords

Immunosuppressive treatment; Myasthenia gravis; Myasthenic crisis

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA; MYASTHENIA CRISIS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AZATHIOPRINE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISOLONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 66749097683     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02634.x     Document Type: Article

References (30)

1. Lacomis D. Myasthenic crisis. Neurocrit Care 2005 3 : 189 194. (Pubitemid 43004811)
2. Seneviratne J, Mandrekar J, Wijdicks EFM, Rabinstein AA. Noninvasives Ventilation in Myasthenic Crisis. Arch Neurol 2008 65 : 54 58.
3. Bedlack RS, Sanders DB. How to handle myasthenic crisis. Postgrad Med 2000 107 : 211 222.
4. Keesey JC. "Crisis" in myasthenia gravis: an historical perspective. Muscle Nerve 2002 26 : 1 3. (Pubitemid 34734390)
5. Berrouschot J, Baumann I, Kalischewski P, Sterker M, Schneider D. Therapy of myasthenic crisis. Crit Care Med 1997 25 : 1228 1235. (Pubitemid 27310266)
6. Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann N Y Acad Sci 1981 377 : 670 677.
7. Rabinstein AA. Update on respiratory management of critically ill neurologic patients. Curr Neurol Neurosci Rep 2005 5 : 476 482. (Pubitemid 41700667)
8. Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 2005 18 : 519 525. (Pubitemid 41476137)
9. Nemoto Y, Kuwabara S, Misawa S, et al. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 2005 76 : 714 718. (Pubitemid 40569685)
10. Newsom-Davis J. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Semin Neurol 2003 23 : 191 198. (Pubitemid 36910119)
11. Varelas PN, Chua ChH, Natterman J, et al. Ventilatory care in myasthenia gravis crisis: Assessing the baseline adverse event rate. Crit Care Med 2002 30 : 2663 2668. (Pubitemid 36870567)
12. Thomas CE, Mayer SA, Gounger Y, et al. Myasthenic crisis: Clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 1997 48 : 1253 1260. (Pubitemid 27240543)
13. Oosterhuis. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989 52 : 1121 1127.
14. Rabinstein A, Wijdicks EFM. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology 2002 59 : 1647 1649. (Pubitemid 35387080)
15. Newsom-Davis J, Vincent A, Wilson SG, Ward CD, Pinching AJ, Hawkey C. Plasmapheresis for myasthenia gravis. N Engl J Med 1978 298 : 456 457.
16. Gajdos P, Chevret S, Chair P, Trauchant Ch, Chastang C. Clinical trial of plasma exchange and high dose intravenous immunoglobulin in myasthenia. Ann Neurol 1997 41 : 789 796. (Pubitemid 27249184)
17. Gajdos P, Trauchant Ch, Clair B, et al. Treatment of Myasthenia Gravis exacerbation with intravenous immunoglobulin. Arch Neurol 2005 62 : 1689 1693.
18. Qureshi AI, Choudhry MA, Akbar MS, et al. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 1999 52 : 629 632. (Pubitemid 29075617)
19. Jani-Acsadi A, Lisak RP. Myasthenic crisis: Guidelines for prevention and treatment. J Neurol Sci 2007 261 : 127 133. (Pubitemid 47313505)
20. EFNS Task Force. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neur 2006 13 : 691 699.
21. Panegyres PK, Squier M, Mills KR, Newsom-Davis J. Acute myopathy associated with large parenteral dose of corticosteroid in myasthenia gravis. J Neurol Neurosurg Psychiatry 1993 56 : 702 704. (Pubitemid 23203774)
22. Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neur 2004 24 : 75 80.
23. Myasthenia Gravis Clinical Study Group. A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. J Neurol Neurosurg Psychiatry 1993 56 : 1157 1163.
24. Palace J, Newsom-Davis J, Lecky B, the Myasthenia Gravis Study Group. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology 1998 50 : 1778 1783. (Pubitemid 28283251)
25. Rozsa C, Lovas G, Fornadi L, Szabo G, Komoly S. Safety of long-term combined immunosuppressive treatment in myasthenia gravis - analysis of adverse effects of 163 patients. Eur J Neurol 2006 9 : 947 952. (Pubitemid 44284900)
26. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Jaretzki A III., Barohn RJ, et al. Myasthenia Gravis. Recommendations for clinical research standards. Neurology 2000 55 : 16 23. (Pubitemid 30460991)
27. Zeitler H, Ulrich-Merzenich G, Hoffmann L, et al. Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis. Artif Org 2006 30 : 597 605. (Pubitemid 44125647)
28. Kokontis L, Gutmann L. Current treatment of neuromuscular diseases. Arch Neurol 2000 57 : 539 943.
29. Cornelio F, Antozzi C, Mantegazza R, et al. Immunosuppressive treatments: their efficacy on Myasthenia Gravis patients outcome an on the natural course of the disease. Ann N Y Acad Sci 1993 681 : 594 602. (Pubitemid 23233888)
30. Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P. Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc 2000 48 : 1442 1448.